Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim in Pediatric ITP
NCT01444417Phase 3Completed
- Sponsor
- Amgen
- Start
- Jan 2012
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of romiplostim in immune thrombocytopenia (ITP), sponsored by Amgen. Started Jan 2012; status: completed.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01444417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444417.